학술논문
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
Document Type
Article
Author
Torka, Pallawi; Groman, Adrienne; Wong, Jerry; Nichols, Jenna; Kader, Angela; Mavis, Cory; Anampa-Guzmán, Andrea; Sait, Sheila Jani; Block, AnneMarie; Przespolewski, Eugene; Mohr, Alice; Lund, Ian; McWhite, Kenneth; Kostrewa, Jessica; DeMarco, Joseph; Johnson, Michael; Darrall, Andrea; Thomas, Roshneke; Sundaram, Suchitra; Ghione, Paola; Hutson, Alan; Hernandez-Ilizaliturri, Francisco J.
Source
In Blood Advances 11 April 2023 7(7):1146-1155
Subject
Language
ISSN
2473-9529